Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a dedicated Locations section and listed Cornwall and Norfolk as locations. Removed the separate Cornwall Locations and Norfolk Locations subsections in the prior revision.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision now shows Revision: v3.3.2 instead of v3.2.0. This appears to be a minor metadata update with no observable changes to the study details or eligibility criteria.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the generic government funding and NIH operating status notice from the page.SummaryDifference0.4%

- Check61 days agoChange DetectedNo significant additions or deletions were detected; the page content and layout remain unchanged, including the study details, eligibility criteria, and locations.SummaryDifference0.4%

- Check90 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that the NIH Clinical Center is open and where to check status.SummaryDifference3%

- Check97 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.